Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes

Journal of Diabetes and its Complications

Volumn 12, Issue 4, 1998, Pages 193-196

  Guerrero Romero, Fernando ^a,b   Rodríguez Morán, Martha ^a,b  

^a Research Group on Diabetes and Chronic Illnesses   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETIC FOOT; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRECIPITATION; PRIORITY JOURNAL; RISK FACTOR; SPECTROPHOTOMETER; TURBIDITY; URINALYSIS;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 0345214532     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00112-8     Document Type: Article

References (24)

1. Guerrero Romero F., Rodriguez Morán M. Diabetes mellitus. Un Análisis de mortalidad por causa básica Rev Med IMSS. 34:1996;43-48.
2. Will C.J., Connell F.A. The preventability of "premature mortality;" an investigation of early diabetes diseases. Am J Public Health. 78:1988;831-833.
3. Romm P.A., Green C.E., Reagan K., Rackley C.E. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol. 67:1991;479-483.
4. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 311:1984;89-93.
5. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 310:1984;356-360.
6. Deckert T., Feldt-Rasmussenet al. Albuminuria reflects widespread vascular damage. The Steno-hipotesis. Diabetologia. 32:1989;219-226.
7. American Diabetes Association Clinical practice recommendations 1997. Diabetic nephropathy. Diabetes Care. 20(suppl 1):1997;S24-S27.
8. Aus A. Alzaid Microlbuminuria in patients with NIDDM. An overview Diabetes Care. 19:1996;79-89.
9. Eastman R.C., Keen H. The impact of cardiovascular disease on people with diabetes. The potential for prevention Lancet. 350(suppl I):1997;29-32.
10. Resck KL, Ernst E, et al.: Can rheology variables be of prognostic relevance in arteriosclerotic disease? Angiology, 963-969, 1991.
11. Nelson R., Knowler W., Pettitt D., Saad M., Charles M.A., Bennet P. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med. 151:1991;1761-1765.
12. Howard E., Lee E.T., Fabsitz R., Robbins D., Yeh J., Cowan L., Welty T. Diabetes and coronary heart disease in American Indians. Diabetes. 45(suppl 3):1996;S6-S13.
13. Paisey R.B., Arredondo G., Villalobos A., Lozano O., Guevara L., Kelly S. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes. A prevalence study of 503 mexican type II diabetic subjects Diabetes Care. 5:1984;421-427.
14. Mendiola I., Mártinez de Jesús F. Morbilidad y mortalidad hospitalaria en la atención integral del diabético. Rev Med IMSS (Mex). 34:1996;303-308.
15. Pedrinelli R., Giampietro O., Carmassi F., Melillo E., Dell'omo G., Catapano G., Matteuci E., Talarico L., Morale M., De Negri F., Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 344:1994;14-18.
16. Yudkin J.S., Jackson C.A. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington diabetes survey Lancet. ii:1988;530-533.
17. Klein R., Klein B., DeMets D. Proteinuria in diabetes. Arch Intern Med. 148:1988;181-186.
18. Guerrero-Romero J.F., Rodríguez-Morán M., Paniagua-Sierra J.R., Salas-Ramires M., Bulnes G., Amato D. Pentoxifylline reduces proteinuria in insulin-dependent and on insulin-dependent diabetic patients. Clin Nephrol. 43:1995;116-121.
19. Uusitupa M., Niskanen L., Siitonen O., Voutilainen E., Pyörälä 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 82:1990;27-36.
20. Haffner S., Stern M., Hazuda H., Mitchell B., Patterson J. Cardiovascular disease risk factors in confirmed prediabetic individuals. JAMA. 263:1990;2893-2898.
21. Scala C., LaPorte R., Dorman J., Songer T., Orchard T., Kuller L., Becker D., Drash A. Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking. Circulation. 82:1990;37-43.
22. Andresen J.L., Rasmussen L.M., Ledet T. Diabetic macroangiopathy and aterosclerosis. Diabetes. 45(suppl 3):1996;S91-S94.
23. González C., Stern M., Arrendondo B., Mártinez S. The level of metabolic control in low income Mexico City diabetics. The Mexico City Diabetes Study. Arch Med Res. 25:1990;387-392.
24. Guerrero-Romero F., Rodríguez-Morán M., Lazcano-Burciaga G., Arellano-Rojas T., Carrillo-Soto V.M., Solís-Morales H. Prevalencia y factores de riesgo asociados a complicaciones vasculares en pacientes con diabetes mellitus no insulin dependiente. Rev Invest Med. SS 2:1997;19-23.